Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
6(50%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_3
1
8%
Ph not_applicable
6
50%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

6

trials recruiting

Total Trials

12

all time

Status Distribution
Active(6)
Completed(1)
Terminated(2)
Other(3)

Detailed Status

Recruiting6
unknown3
Withdrawn1
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
6
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (14.3%)
N/A6 (85.7%)

Trials by Status

unknown325%
withdrawn18%
terminated18%
completed18%
recruiting650%

Recent Activity

6 active trials
Showing 5 of 12
recruitingnot_applicable

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

NCT05976685
recruiting

Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

NCT06075628
withdrawnnot_applicable

Pulsed Field Ablation During Left Atrial Appendage Occlusion: A Randomised Controlled Trial

NCT06334250
recruiting

Left Atrial Appendage Occlusion Registry (LAAO Registry)

NCT02699957
unknown

Hemostatic Activity Following LAAO

NCT05011981
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05976685Not Applicable

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

Recruiting
NCT06075628

Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

Recruiting
NCT06334250Not Applicable

Pulsed Field Ablation During Left Atrial Appendage Occlusion: A Randomised Controlled Trial

Withdrawn
NCT02699957

Left Atrial Appendage Occlusion Registry (LAAO Registry)

Recruiting
NCT05011981

Hemostatic Activity Following LAAO

Unknown
NCT06060912Not Applicable

LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs

Recruiting
NCT03642509Not Applicable

Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation

Recruiting
NCT01561651Not Applicable

Left Atrial Appendage Occlusion Study III

Completed
NCT03428048

Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.

Recruiting
NCT02039167Not Applicable

Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease

Terminated
NCT03108872

Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation

Unknown
NCT01628068Phase 3

ELIGIBLE (Efficacy of Left atrIal Appendage Closure After GastroIntestinal BLEeding)

Unknown

All 12 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
12